Findings in an upcoming publication in the Journal of Molecular Diagnostics show CombiMatrix’s HemeScan test is superior to conventional testing for the clinical evaluation and prognosis of CLL patients.
Read More
Xpert BCR-ABL Monitor Assay for the GeneXpert System CML genetic marker assay The Xpert BCR-ABL monitor from Cepheid, Sunnyvale, Calif, can be used by hematologist-oncologists and laboratorians as an aid in the monitoring of BCR-ABL, an
Read MoreCombiMatrix Corp, Mukilteo, Wash, and Clarient, Inc, Aliso Viejo, Calif, have partnered for HemeScan, a genomics-based cancer test for the treatment and care of chronic lymphocytic leukemia, and other cancers.
Read MoreThe FDA has approved the fully automated HTLV-I/HTLV-II blood-screening test from Abbott, Abbott Park, Ill, for use on the companys Prism instrument.
Read MoreGenzyme Genetics, Cambridge, Mass, a nationwide provider of genetic testing and counseling services for physicians and patients, plans to participate in a multi-center Cancer and Leukemia Group B study that will include 1,700 newly diagnosed patients with chronic lymphocytic leukemia.
Read More